z-logo
open-access-imgOpen Access
Phase II study of continuous daily sunitinib dosing in patients with previously treated advanced non-small cell lung cancer
Author(s) -
S. Novello,
Giorgio V. Scagliotti,
R. Rosell,
Mark A. Socinski,
J. Brahmer,
J. Atkins,
C. Pallares,
R. Burgess,
L. Tye,
P. Selaru,
E. Wang,
R. Chao,
R. Govindan
Publication year - 2009
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/z01a-7t05
Subject(s) - sunitinib , dosing , lung cancer , continuous infusion , medicine , oncology , phase (matter) , pharmacology , cancer , chemistry , organic chemistry

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here